title: [Complement--a phylogenetically old system as a new player in the development of atherosclerosis].
abstract: Atherosclerotic diseases such as coronary artery disease and ischaemic stroke are caused by chronic inflammation in arterial vessel walls. The complement system is part of the innate immune system. It is involved in many processes contributing to onset and development of atherosclerotic plaques up to the final stage of acute thrombotic events. This is due to its prominent role in inflammatory processes. In addition, there is increasing evidence that interactions between complement and coagulation provide a link between inflammation and thrombosis. On the other hand, the complement system also has an atheroprotective function through the clearance of apoptotic material.  The knowledge of these complex mechanisms will become increasingly important, also for clinicians, since it may lead to novel therapeutic and diagnostic options. Therapies targeting the complement system have the potential to reduce tissue damage caused by acute ischaemic events. Whether early anti-inflammatory and anti-complement therapy may be able to prevent atherosclerosis, remains a hot topic for research.
authors.affiliation: Universitätsklinik für Hämatologie, Hämostase Forschungslabor, Universitätsspital und Universität Bern, Schweiz.
authors.forename: V
authors.initials: V
authors.lastname: Frauenknecht
authors.forename: V
authors.initials: V
authors.lastname: Schroeder
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000276:immunology*; D001777:Blood Coagulation / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology*; D006801:Humans; D018448:Models, Immunological
chemical_list: D003165:Complement System Proteins